[Press Release] Oncodesign : 2018 annual results


[Congress] 2nd Annual 3D Tissue Models Oncology - 7-9 May - Boston - USA

2nd Annual 3D Tissue Models Oncology - 7-9 mai - Boston

Phil Kasprzyk, Business Development Manager, will be there to meet you and to discuss about innovative predictive tools for IO combination available at Oncodesign:

- In-vitro / in-vivo pharmacology of immune checkpoint inhibitors
- Translational human reconstituted immune system in cancer models
- Translational cancer biomarkers


I fix a meeting!


[Congress] 2019 77th Annual SID Meeting – 8-11 May – Chicago - USA

77th Annual SID Meeting – 8-11 Mai – Chicago

Scott Barksdale, Business Development Manager, will attend this annual meeting.
This will be a great opportunity to interact with scientists on the latest advances discussed during the conferences.
We will be also pleased to let you know about our new mouse model of colitis induced by anti-CTLA-4 that can mimic the side effects of immunotherapies (diarrhea and colitis).

I fix a meeting

[Congress] Meet2Win – 21- 22 May - Bordeaux - France

Meet2Win –May  21- 22 – Bordeaux

Our experts will be present:

  • Round table "Quoi de neuf autour de l’innovation en oncologie ?"  with the participation of Mr. Sébastien Vachenc - Head of the Data Sciences Lab and OncoSNIPE® Program Director.
  • As participant to networking sessions to unveil our competencies in oncology/IO with our consortium IMODI and our broader panel of offerings in inflammatory & infectious diseases (from target identification, lead optimization to IND).



I fix a meeting! 

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.